The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
928
August 5, 1994
View Complete Issue         Table of Contents 2019 
An ACE inhibitor after a Myocardial Infarction
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
An ACE inhibitor after a Myocardial Infarction
August 5, 1994 (Issue: 928)
The US Food and Drug Administration has approved use of the angiotensin-converting enzyme (ACE) inhibitor captopril (Capoten) for patients with left ventricular dysfunction after a myocardial infarction. ACE inhibitors, widely used for treatment of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: An ACE inhibitor after a Myocardial Infarction
Article code: 928a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.